USPH
U S PHYSICAL THERAPY INC /NV
Company overview
- Market capitalization
- $1.28B
- Employees
- 4,653
- Latest publication
- 2026-09-29
About U S PHYSICAL THERAPY INC /NV
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20202020-03-31 · USD | Q4 20082008-12-31 · USD | Q3 20082008-09-30 · USD | Q2 20082008-06-30 · USD | Q1 20082008-03-31 · USD | Q4 20072007-12-31 · USD | Q3 20072007-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 214,059,000USD | 112,717,000USD | 47,814,000USD | 47,232,000USD | 47,389,000USD | 45,251,000USD | 44,154,000USD | 37,453,000USD |
| Cost Of Revenue | 153,111,000USD | 97,026,000USD | 35,839,000USD | 35,877,000USD | 34,663,000USD | 33,704,000USD | 35,521,000USD | 27,758,000USD |
| Gross Profit | 41,943,000USD | 15,691,000USD | 11,975,000USD | 11,355,000USD | 12,726,000USD | 11,547,000USD | 8,633,000USD | 9,695,000USD |
| Selling General Administrative | 19,005,000USD | 11,677,000USD | 6,327,000USD | 5,424,000USD | 6,166,000USD | 5,810,000USD | 2,896,000USD | 4,900,000USD |
| Total Operating Expenses | 19,997,000USD | 11,677,000USD | 6,327,000USD | 5,424,000USD | 6,166,000USD | 5,810,000USD | 2,896,000USD | 4,900,000USD |
| Operating Income | 21,946,000USD | 4,014,000USD | 5,648,000USD | 5,931,000USD | 6,560,000USD | 5,737,000USD | 5,737,000USD | 4,795,000USD |
| Total Other Income Expense Net | -2,893,000USD | -384,000USD | -1,964,000USD | -182,000USD | -1,842,000USD | -124,000USD | -1,721,000USD | -1,366,000USD |
| Interest Income | 29,000USD | 43,000USD | — | — | — | — | — | — |
| Labor And Related Expense | 125,404,000USD | — | — | — | — | — | — | — |
| Income Before Tax | 19,053,000USD | 3,630,000USD | 3,684,000USD | 4,166,000USD | 4,718,000USD | 3,941,000USD | 4,016,000USD | 3,429,000USD |
| Income Tax Expense | 4,155,000USD | 292,000USD | 1,451,000USD | 1,635,000USD | 1,863,000USD | 1,556,000USD | 1,534,000USD | 1,297,000USD |
| Equity Method Income Loss | 408,000USD | — | — | — | — | — | — | — |
| Net Income | 14,898,000USD | 2,586,000USD | 2,233,000USD | 2,531,000USD | 2,855,000USD | 2,385,000USD | 2,640,000USD | 2,120,000USD |
| Minority Interest | 5,000,000USD | 2,322,000USD | 1,853,000USD | 1,583,000USD | 1,977,000USD | 1,672,000USD | 1,576,000USD | 1,369,000USD |
| Net Income Applicable To Common Shares | 9,898,000USD | 1,016,000USD | 2,233,000USD | 2,531,000USD | 2,855,000USD | 2,385,000USD | 2,482,000USD | 2,132,000USD |
| Interest Expense | — | 427,000USD | 121,000USD | 158,000USD | 114,000USD | 149,000USD | 166,000USD | 84,000USD |
| Net Interest Income | — | -384,000USD | — | — | — | — | — | — |
| Tax Provision | — | 292,000USD | — | — | — | — | — | — |
| Net Income From Continuing Ops | — | 3,338,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Ebit | — | 4,057,000USD | 5,648,000USD | 4,389,000USD | 6,809,000USD | 5,762,000USD | 5,737,000USD | 3,548,000USD |
| Ebitda | — | 6,664,000USD | 7,168,000USD | 5,931,000USD | 8,229,000USD | 7,246,000USD | 7,193,000USD | 4,795,000USD |
| Depreciation And Amortization | — | 2,607,000USD | 1,520,000USD | 1,542,000USD | 1,420,000USD | 1,484,000USD | 1,456,000USD | 1,247,000USD |
| Reconciled Depreciation | — | 2,607,000USD | 1,520,000USD | 1,542,000USD | 1,420,000USD | 1,484,000USD | 1,456,000USD | 1,247,000USD |
| Non Operating Income Net Other | — | 43,000USD | — | — | — | — | — | — |
| Research Development | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Discontinued Operations | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Source | 0001140361-26-031825DeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20082008-12-31 · USD | FY 20072007-12-31 · USD | FY 20052005-12-31 · USD | FY 20042004-12-31 · USD | FY 20032003-12-31 · USD | FY 20022002-12-31 · USD | FY 20012001-12-31 · USD | FY 20002000-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 187,686,000USD | 151,686,000USD | 132,122,000USD | 118,308,000USD | 105,568,000USD | 94,739,000USD | 80,948,000USD | 63,222,000USD |
| Cost Of Revenue | 140,083,000USD | 114,325,000USD | 96,210,000USD | 85,275,000USD | 74,604,000USD | 64,531,000USD | 54,880,000USD | 42,900,000USD |
| Gross Profit | 47,603,000USD | 37,361,000USD | 35,912,000USD | 33,033,000USD | 30,964,000USD | 30,208,000USD | 26,068,000USD | 20,322,000USD |
| Selling General Administrative | 23,727,000USD | 17,326,000USD | 16,425,000USD | 16,802,000USD | 13,967,000USD | 11,334,000USD | 9,120,000USD | 7,607,000USD |
| Total Operating Expenses | 23,727,000USD | 17,326,000USD | 17,029,000USD | 17,040,000USD | 13,967,000USD | 11,334,000USD | 9,120,000USD | 9,938,000USD |
| Operating Income | 23,876,000USD | 20,035,000USD | 18,883,000USD | 15,993,000USD | 16,997,000USD | 18,874,000USD | 16,948,000USD | 10,384,000USD |
| Interest Expense | 542,000USD | 301,000USD | 361,000USD | 0USD | 189,000USD | 214,000USD | 266,000USD | 780,000USD |
| Income Before Tax | 16,509,000USD | 14,280,000USD | 14,302,000USD | 10,777,000USD | 11,783,000USD | 13,724,000USD | 11,503,000USD | 6,138,000USD |
| Income Tax Expense | 6,505,000USD | 5,465,000USD | 5,511,000USD | 4,099,000USD | 4,452,000USD | 5,236,000USD | 4,432,000USD | 2,403,000USD |
| Net Income | 10,004,000USD | 8,892,000USD | 8,791,000USD | 6,678,000USD | 7,331,000USD | 8,488,000USD | 7,071,000USD | 3,735,000USD |
| Ebit | 24,136,000USD | 20,035,000USD | 20,527,000USD | 16,505,000USD | 16,997,000USD | 18,874,000USD | 16,948,000USD | 10,384,000USD |
| Ebitda | 30,102,000USD | 25,021,000USD | 24,835,000USD | 20,827,000USD | 20,588,000USD | 21,829,000USD | 19,514,000USD | 12,715,000USD |
| Depreciation And Amortization | 5,966,000USD | 4,986,000USD | 4,308,000USD | 4,322,000USD | 3,591,000USD | 2,955,000USD | 2,566,000USD | 2,331,000USD |
| Total Other Income Expense Net | -282,000USD | -5,755,000USD | -5,612,000USD | -366,000USD | -5,159,000USD | -5,064,000USD | -5,445,000USD | -4,246,000USD |
| Minority Interest | 7,085,000USD | 5,727,000USD | 4,908,000USD | 5,362,000USD | 5,025,000USD | 4,936,000USD | 5,179,000USD | 3,466,000USD |
| Net Income Applicable To Common Shares | 10,004,000USD | 8,815,000USD | 8,791,000USD | 6,678,000USD | 7,331,000USD | 8,488,000USD | 7,071,000USD | 3,735,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | — | 2,331,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,248,874,000USD | 1,242,057,000USD | 1,204,010,000USD | 1,196,270,000USD | 1,179,600,000USD | 1,179,687,000USD | 1,167,467,000USD | 1,029,191,000USD |
| Cash And Equivalents | 24,887,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 139,675,000USD | 139,109,000USD | 139,990,000USD | 138,435,000USD | 140,532,000USD | 145,353,000USD | 137,583,000USD | 204,870,000USD |
| Other Current Assets | 16,628,000USD | 13,946,000USD | 16,084,000USD | 16,032,000USD | 13,061,000USD | 15,274,000USD | 10,555,000USD | 10,833,000USD |
| Other Non Current Assets | 6,505,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 482,216,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 109,909,000USD | 117,298,000USD | 139,040,000USD | 115,080,000USD | 118,842,000USD | 123,795,000USD | 116,283,000USD | 115,300,000USD |
| Other Current Liabilities | 10,134,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 2,954,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 448,656,000USD | 468,975,000USD | 476,432,000USD | 503,567,000USD | 500,750,000USD | 497,261,000USD | 488,929,000USD | 482,758,000USD |
| Total Equity Including Noncontrolling Interest | 766,658,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 4,563,000USD | 10,801,000USD | 9,865,000USD | 8,802,000USD | 8,168,000USD | 9,257,000USD | 10,999,000USD | 9,605,000USD |
| Long Term Debt | 215,456,000USD | 194,040,000USD | 152,594,000USD | 151,460,000USD | 151,914,000USD | 157,238,000USD | 142,530,000USD | 132,916,000USD |
| Deferred Revenue | 753,000USD | — | — | — | — | — | — | — |
| Net Receivables | 69,603,000USD | 96,724,000USD | 88,336,000USD | 91,301,000USD | 93,385,000USD | 90,896,000USD | 85,666,000USD | 77,078,000USD |
| Property Plant Equipment Net | 196,900,000USD | 187,824,000USD | 271,073,000USD | 174,148,000USD | 169,369,000USD | 165,961,000USD | 166,076,000USD | 130,503,000USD |
| Goodwill | 716,535,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 176,547,000USD | 179,819,000USD | 172,861,000USD | 176,429,000USD | 175,627,000USD | 177,328,000USD | 179,311,000USD | 124,309,000USD |
| Accounts Payable | 6,917,000USD | 6,758,000USD | 6,059,000USD | 7,417,000USD | 4,200,000USD | 6,088,000USD | 5,936,000USD | 6,361,000USD |
| Short Term Debt | 42,871,000USD | 53,580,000USD | 51,999,000USD | 50,762,000USD | 49,206,000USD | 49,381,000USD | 50,834,000USD | 44,433,000USD |
| Common Stock | 175,000USD | 175,000USD | 174,000USD | 172,000USD | 172,000USD | 172,000USD | 172,000USD | 172,000USD |
| Retained Earnings | 213,361,000USD | 216,876,000USD | 227,216,000USD | 237,272,000USD | 236,356,000USD | 234,161,000USD | 227,265,000USD | 225,873,000USD |
| Accumulated Other Comprehensive Income | 1,047,000USD | 978,000USD | 714,000USD | 945,000USD | 1,214,000USD | 1,783,000USD | 2,799,000USD | 1,339,000USD |
| Total Liab | — | 459,186,000USD | 433,811,000USD | 413,827,000USD | 414,008,000USD | 420,679,000USD | 408,421,000USD | 358,473,000USD |
| Other Current Liab | — | 55,930,000USD | 80,982,000USD | 56,901,000USD | 64,872,000USD | 67,860,000USD | 54,598,000USD | 58,327,000USD |
| Capital Stock | — | 175,000USD | 174,000USD | 172,000USD | 172,000USD | 172,000USD | 172,000USD | 172,000USD |
| Good Will | — | 715,874,000USD | 692,392,000USD | 690,412,000USD | 677,595,000USD | 674,387,000USD | 667,152,000USD | 554,642,000USD |
| Cash | — | 28,439,000USD | 35,570,000USD | 31,102,000USD | 34,086,000USD | 39,183,000USD | 41,362,000USD | 116,959,000USD |
| Cash And Short Term Investments | — | 28,439,000USD | 35,570,000USD | 31,102,000USD | 34,086,000USD | 39,183,000USD | 41,362,000USD | 116,959,000USD |
| Current Deferred Revenue | — | 1,030,000USD | — | — | — | — | — | — |
| Net Debt | — | 334,393,000USD | 390,167,000USD | 277,298,000USD | 271,313,000USD | 268,124,000USD | 253,870,000USD | 137,391,000USD |
| Short Long Term Debt Total | — | 362,832,000USD | 425,737,000USD | 308,400,000USD | 305,399,000USD | 307,307,000USD | 295,232,000USD | 254,350,000USD |
| Long Term Investments | — | 12,443,000USD | 12,275,000USD | 12,289,000USD | 12,320,000USD | 12,273,000USD | 12,190,000USD | 12,168,000USD |
| Property Plant Equipment Gross | — | 280,953,000USD | 271,073,000USD | 265,463,000USD | 259,222,000USD | 255,503,000USD | 253,169,000USD | 219,105,000USD |
| Common Stock Shares Outstanding | — | 15,167,000shares | 15,175,000shares | 15,204,000shares | 15,197,000shares | 15,132,000shares | 15,064,000shares | 15,077,000shares |
| Non Current Assets Total | — | 1,102,948,000USD | 1,064,020,000USD | 1,057,835,000USD | 1,039,068,000USD | 1,034,334,000USD | 1,029,884,000USD | 824,321,000USD |
| Non Current Liabilities Total | — | 341,888,000USD | 294,771,000USD | 298,747,000USD | 295,166,000USD | 296,884,000USD | 292,138,000USD | 243,173,000USD |
| Non Current Liabilities Other | — | 1,861,000USD | 3,214,000USD | 5,414,000USD | 4,571,000USD | 4,903,000USD | 18,275,000USD | 8,343,000USD |
| Non Currrent Assets Other | — | 6,988,000USD | -84,581,000USD | 4,557,000USD | 4,157,000USD | 4,385,000USD | 5,155,000USD | 2,699,000USD |
| Net Working Capital | — | 21,811,000USD | 950,000USD | 23,355,000USD | 21,690,000USD | 21,558,000USD | 21,300,000USD | 89,570,000USD |
| Unclassified Current Liabilities | — | -10,801,000USD | -9,865,000USD | -8,802,000USD | -7,604,000USD | -8,791,000USD | -6,084,000USD | -3,426,000USD |
| Unclassified Non Current Liabilities | — | 145,987,000USD | 138,963,000USD | 141,873,000USD | 138,681,000USD | 134,743,000USD | 131,333,000USD | 101,914,000USD |
| Unclassified Equity | — | 250,771,000USD | 248,154,000USD | 265,006,000USD | 262,836,000USD | 260,973,000USD | 258,521,000USD | 255,202,000USD |
| Unclassified Non Current Assets | — | — | -84,581,000USD | — | — | — | — | — |
| Source | 0001140361-26-031825DeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,204,010,000USD | 1,167,467,000USD | 997,238,000USD | 858,154,000USD | 749,426,000USD | 594,361,000USD | 560,845,000USD | 443,166,000USD |
| Intangible Assets | 172,861,000USD | 179,311,000USD | 109,682,000USD | 108,755,000USD | 86,382,000USD | 56,280,000USD | 52,588,000USD | 48,828,000USD |
| Other Current Assets | 16,084,000USD | 10,555,000USD | 10,830,000USD | 10,367,000USD | 4,183,000USD | 3,773,000USD | 5,787,000USD | 11,095,000USD |
| Total Liab | 433,811,000USD | 408,421,000USD | 345,000,000USD | 373,586,000USD | 296,983,000USD | 184,391,000USD | 181,394,000USD | 92,348,000USD |
| Total Stockholder Equity | 476,432,000USD | 488,929,000USD | 476,194,000USD | 315,793,000USD | 295,606,000USD | 276,160,000USD | 240,257,000USD | 215,945,000USD |
| Other Current Liab | 80,982,000USD | 54,598,000USD | 53,983,000USD | 37,136,000USD | 42,989,000USD | 49,861,000USD | 30,855,000USD | 38,493,000USD |
| Common Stock | 174,000USD | 172,000USD | 172,000USD | 152,000USD | 151,000USD | 151,000USD | 150,000USD | 149,000USD |
| Capital Stock | 174,000USD | 172,000USD | 172,000USD | 152,000USD | 151,000USD | 151,000USD | 150,000USD | 149,000USD |
| Retained Earnings | 227,216,000USD | 227,265,000USD | 223,772,000USD | 232,948,000USD | 224,395,000USD | 212,015,000USD | 184,352,000USD | 167,396,000USD |
| Good Will | 692,392,000USD | 667,152,000USD | 509,571,000USD | 494,101,000USD | 434,679,000USD | 345,646,000USD | 317,676,000USD | 293,525,000USD |
| Cash | 35,570,000USD | 41,362,000USD | 152,825,000USD | 31,594,000USD | 28,567,000USD | 32,918,000USD | 23,548,000USD | 23,368,000USD |
| Cash And Short Term Investments | 35,570,000USD | 41,362,000USD | 152,825,000USD | 31,594,000USD | 28,567,000USD | 32,918,000USD | 23,548,000USD | 23,368,000USD |
| Total Current Assets | 139,990,000USD | 137,583,000USD | 233,375,000USD | 111,266,000USD | 95,166,000USD | 87,636,000USD | 85,386,000USD | 79,214,000USD |
| Total Current Liabilities | 139,040,000USD | 116,283,000USD | 102,185,000USD | 85,489,000USD | 83,481,000USD | 93,492,000USD | 60,563,000USD | 41,946,000USD |
| Net Debt | 390,167,000USD | 253,870,000USD | 105,762,000USD | 263,743,000USD | 194,510,000USD | 78,074,000USD | 114,285,000USD | 16,468,000USD |
| Short Term Debt | 51,999,000USD | 50,834,000USD | 42,943,000USD | 41,572,000USD | 31,305,000USD | 32,411,000USD | 27,214,000USD | 1,434,000USD |
| Short Long Term Debt | 9,865,000USD | 10,999,000USD | 7,691,000USD | 7,863,000USD | 830,000USD | 4,899,000USD | 728,000USD | 1,434,000USD |
| Short Long Term Debt Total | 425,737,000USD | 295,232,000USD | 258,587,000USD | 295,337,000USD | 223,077,000USD | 110,992,000USD | 137,833,000USD | 39,836,000USD |
| Long Term Debt | 152,594,000USD | 142,530,000USD | 138,991,000USD | 175,831,000USD | 117,587,000USD | 16,596,000USD | 50,361,000USD | 38,402,000USD |
| Long Term Investments | 12,275,000USD | 12,190,000USD | 12,256,000USD | 12,131,000USD | 12,215,000USD | 0USD | — | — |
| Net Receivables | 88,336,000USD | 85,666,000USD | 69,720,000USD | 69,305,000USD | 62,416,000USD | 50,945,000USD | 56,051,000USD | 51,493,000USD |
| Accounts Payable | 6,059,000USD | 5,936,000USD | 3,898,000USD | 6,504,000USD | 6,471,000USD | 1,335,000USD | 2,494,000USD | 2,019,000USD |
| Property Plant Equipment Net | 271,073,000USD | 166,076,000USD | 129,533,000USD | 127,752,000USD | 119,406,000USD | 103,260,000USD | 103,676,000USD | 20,169,000USD |
| Property Plant Equipment Gross | 271,073,000USD | 253,169,000USD | 214,354,000USD | 207,955,000USD | 97,937,000USD | 103,260,000USD | 103,676,000USD | 20,169,000USD |
| Accumulated Other Comprehensive Income | 714,000USD | 2,799,000USD | 2,782,000USD | 4,004,000USD | 0USD | 0USD | 0USD | -64,154,000USD |
| Common Stock Shares Outstanding | 15,175,000shares | 15,064,000shares | 14,188,000shares | 12,985,000shares | 12,898,000shares | 12,835,000shares | 12,756,000shares | 12,666,000shares |
| Non Current Assets Total | 1,064,020,000USD | 1,029,884,000USD | 763,863,000USD | 746,888,000USD | 654,260,000USD | 506,725,000USD | 475,459,000USD | 363,952,000USD |
| Non Current Liabilities Total | 294,771,000USD | 292,138,000USD | 242,815,000USD | 288,097,000USD | 213,502,000USD | 90,899,000USD | 120,831,000USD | 50,402,000USD |
| Non Current Liabilities Other | 3,214,000USD | 18,275,000USD | 2,356,000USD | 13,029,000USD | 7,345,000USD | 4,539,000USD | 141,000USD | 829,000USD |
| Non Currrent Assets Other | -84,581,000USD | 5,155,000USD | 2,821,000USD | 4,149,000USD | 1,578,000USD | 1,539,000USD | 1,519,000USD | 1,430,000USD |
| Net Working Capital | 950,000USD | 21,300,000USD | 131,190,000USD | 25,777,000USD | 11,685,000USD | -5,856,000USD | 24,823,000USD | 37,268,000USD |
| Unclassified Non Current Assets | -84,581,000USD | — | — | — | — | -14,053,000USD | — | — |
| Unclassified Current Liabilities | -9,865,000USD | -6,084,000USD | -6,330,000USD | -7,586,000USD | 1,886,000USD | 4,986,000USD | — | -1,434,000USD |
| Unclassified Non Current Liabilities | 138,963,000USD | 131,333,000USD | 101,468,000USD | 64,905,000USD | 66,840,000USD | 57,446,000USD | 60,117,000USD | -2,988,000USD |
| Unclassified Equity | 248,154,000USD | 258,521,000USD | 249,296,000USD | 78,537,000USD | 102,537,000USD | 95,471,000USD | 87,233,000USD | 144,033,000USD |
| Short Term Investments | — | — | 2,663,000USD | 2,858,000USD | — | — | — | — |
| Inventory | — | — | -2,663,000USD | -2,858,000USD | 1USD | 1USD | 1USD | — |
| Unclassified Current Assets | — | — | -2,663,000USD | -2,858,000USD | — | — | — | -6,742,000USD |
| Other Liab | — | — | — | 34,332,000USD | 21,730,000USD | 12,318,000USD | 10,212,000USD | 12,000,000USD |
| Other Assets | — | — | — | 1,629,000USD | 1,578,000USD | 14,053,000USD | 1,519,000USD | 1,430,000USD |
| Net Tangible Assets | — | — | — | -287,063,000USD | -225,455,000USD | 6,574,000USD | 7,743,000USD | 7,535,000USD |
| Accumulated Depreciation | — | — | — | — | -74,958,000USD | -69,081,000USD | -66,099,000USD | -64,154,000USD |
| Treasury Stock | — | — | — | — | -31,628,000USD | -31,628,000USD | -31,628,000USD | -31,628,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 2,159,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 11,935,000USD |
| Stock Based Compensation | 5,479,000USD |
| Deferred Income Tax | 5,232,000USD |
| Other Non Cash Items | -124,000USD |
| Change To Account Receivables | -9,047,000USD |
| Change To Liabilities | -2,371,000USD |
| Change In Working Capital | -10,383,000USD |
| Operating Cash Flow | 38,178,000USD |
| Capital Expenditures | -10,737,000USD |
| Other Investing Activities | -21,298,000USD |
| Unclassified Investing Cash Flow | -14,172,000USD |
| Investing Cash Flow | -46,207,000USD |
| Net Debt Issuance | 43,750,000USD |
| Net Common Stock Issuance | -19,233,000USD |
| Common Dividends Paid | -13,871,000USD |
| Unclassified Financing Cash Flow | -13,300,000USD |
| Financing Cash Flow | -2,654,000USD |
| Change In Cash | -10,683,000USD |
| End Cash Flow | 24,887,000USD |
| Source | 0001140361-26-031825DeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,844,000USD | 5,606,000USD | 17,642,000USD | 17,720,000USD | 9,899,000USD | 12,494,000USD | 9,777,000USD | 7,043,000USD |
| Depreciation | 6,000,000USD | 4,635,000USD | 5,832,000USD | 6,057,000USD | 5,867,000USD | 5,685,000USD | 4,387,000USD | 4,514,000USD |
| Stock Based Compensation | 2,310,000USD | 2,119,000USD | 2,263,000USD | 2,117,000USD | 1,771,000USD | 1,986,000USD | 1,921,000USD | 1,919,000USD |
| Other Non Cash Items | 15,984,000USD | 10,204,000USD | -3,410,000USD | 1,685,000USD | 835,000USD | -336,000USD | 3,388,000USD | 12,641,000USD |
| Change To Account Receivables | -8,483,000USD | 985,000USD | -168,000USD | -3,310,000USD | -7,341,000USD | 3,524,000USD | -1,409,000USD | 1,648,000USD |
| Change In Working Capital | -19,425,000USD | 2,125,000USD | -6,271,000USD | 5,245,000USD | -28,289,000USD | -5,180,000USD | 2,812,000USD | 6,132,000USD |
| Total Cash From Operating Activities | 4,003,000USD | 24,932,000USD | 19,940,000USD | 34,861,000USD | -4,675,000USD | 19,409,000USD | 22,120,000USD | 29,157,000USD |
| Capital Expenditures | -5,373,000USD | -3,926,000USD | -4,315,000USD | -3,251,000USD | -2,579,000USD | -2,489,000USD | -2,523,000USD | -2,336,000USD |
| Free Cash Flow | -1,370,000USD | 21,006,000USD | 15,625,000USD | 31,610,000USD | -7,254,000USD | 16,920,000USD | 19,597,000USD | 26,821,000USD |
| Total Cashflows From Investing Activities | -39,996,000USD | -5,444,000USD | -11,935,000USD | -12,706,000USD | -6,628,000USD | -94,853,000USD | -5,842,000USD | -28,456,000USD |
| Net Borrowings | 41,550,000USD | 2,054,000USD | -241,000USD | -6,530,000USD | 12,777,000USD | 9,774,000USD | -2,488,000USD | — |
| Total Cash From Financing Activities | 28,862,000USD | -15,020,000USD | -10,989,000USD | -27,252,000USD | 9,124,000USD | -153,000USD | -12,230,000USD | -20,080,000USD |
| Dividends Paid | -7,006,000USD | -6,842,000USD | -6,842,000USD | -13,678,000USD | -6,836,000USD | -6,642,000USD | -6,634,000USD | -13,264,000USD |
| Change In Cash | -7,131,000USD | 4,468,000USD | -2,984,000USD | -5,097,000USD | -2,179,000USD | -75,597,000USD | 4,048,000USD | -19,378,999USD |
| Begin Period Cash Flow | 35,570,000USD | 31,102,000USD | 34,086,000USD | 39,183,000USD | 41,362,000USD | 116,959,000USD | 112,911,000USD | 132,289,999USD |
| End Period Cash Flow | 28,439,000USD | 35,570,000USD | 31,102,000USD | 34,086,000USD | 39,183,000USD | 41,362,000USD | 116,959,000USD | 112,911,000USD |
| Other Cashflows From Investing Activities | 324,000USD | 299,000USD | 769,000USD | 884,000USD | 354,000USD | 1,020,000USD | -22,000USD | 156,000USD |
| Other Cashflows From Financing Activities | -12,688,000USD | -4,665,999USD | -3,906,000USD | -7,044,000USD | 3,183,000USD | -3,285,000USD | -3,108,000USD | -5,158,000USD |
| Unclassified Investing Cash Flow | -34,947,000USD | -1,817,000USD | 3,546,000USD | 2,367,000USD | 2,225,000USD | 1,469,000USD | 2,545,000USD | 2,015,000USD |
| Unclassified Financing Cash Flow | 7,006,000USD | — | — | — | — | — | — | -1,658,000USD |
| Sale Purchase Of Stock | — | -5,566,000USD | — | — | — | — | — | — |
| Investments | — | — | -11,935,000USD | -12,706,000USD | -6,628,000USD | -94,853,000USD | -5,842,000USD | -28,291,000USD |
| Unclassified Operating Cash Flow | — | — | 3,884,000USD | 2,037,000USD | 5,242,000USD | 4,760,000USD | — | -3,092,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 58,005,000USD | 45,600,000USD | 37,220,000USD | 43,407,000USD | 57,924,000USD | 52,491,000USD | 57,259,000USD | 48,842,000USD |
| Depreciation | 22,391,000USD | 18,681,000USD | 15,695,000USD | 14,743,000USD | 11,591,000USD | 10,533,000USD | 10,095,000USD | 9,755,000USD |
| Stock Based Compensation | 8,270,000USD | 7,823,000USD | 7,236,000USD | 7,264,000USD | 7,867,000USD | 7,917,000USD | 6,985,000USD | 5,939,000USD |
| Other Non Cash Items | 2,176,000USD | 9,875,000USD | 22,266,000USD | 10,244,000USD | 5,059,000USD | 5,672,000USD | -560,000USD | 2,924,000USD |
| Change To Account Receivables | -9,060,000USD | -11,894,000USD | -6,001,000USD | -10,279,000USD | -9,417,000USD | 899,000USD | -6,376,000USD | -3,434,000USD |
| Change In Working Capital | -27,190,000USD | -12,404,000USD | -4,929,000USD | -21,430,000USD | -11,723,000USD | 23,640,000USD | -15,982,000USD | 732,000USD |
| Total Cash From Operating Activities | 75,058,000USD | 74,940,000USD | 81,978,000USD | 58,537,000USD | 76,406,000USD | 99,995,000USD | 62,448,000USD | 73,005,000USD |
| Capital Expenditures | -14,071,000USD | -9,186,000USD | -9,294,000USD | -8,248,000USD | -8,201,000USD | -7,639,000USD | -10,189,000USD | -7,193,000USD |
| Free Cash Flow | 60,987,000USD | 65,754,000USD | 72,684,000USD | 50,289,000USD | 68,205,000USD | 92,356,000USD | 52,259,000USD | 65,812,000USD |
| Total Cashflows From Investing Activities | -36,713,000USD | -149,450,000USD | -45,015,000USD | -81,269,000USD | -124,136,000USD | -51,203,000USD | -37,993,000USD | -23,909,000USD |
| Net Borrowings | 8,060,000USD | 4,298,000USD | -39,150,000USD | 64,195,000USD | 93,101,000USD | -31,037,000USD | 6,567,000USD | -20,044,000USD |
| Total Cash From Financing Activities | -44,137,000USD | -36,953,000USD | 84,268,000USD | 25,759,000USD | 43,379,000USD | -39,422,000USD | -24,275,000USD | -47,661,000USD |
| Dividends Paid | -27,362,000USD | -26,540,000USD | -24,128,000USD | -21,321,000USD | -18,765,000USD | -4,110,000USD | -14,555,000USD | -11,664,000USD |
| Sale Purchase Of Stock | -5,566,000USD | 0USD | 0USD | — | 914,000USD | — | 502,000USD | -265,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 163,646,000USD | 0USD | 0USD | — | — | — |
| Change In Cash | -5,792,000USD | -111,463,000USD | 121,231,000USD | 3,027,000USD | -4,351,000USD | 9,370,000USD | 180,000USD | 1,435,000USD |
| Begin Period Cash Flow | 41,362,000USD | 152,825,000USD | 31,594,000USD | 28,567,000USD | 32,918,000USD | 23,548,000USD | 23,368,000USD | 21,933,000USD |
| End Period Cash Flow | 35,570,000USD | 41,362,000USD | 152,825,000USD | 31,594,000USD | 28,567,000USD | 32,918,000USD | 23,548,000USD | 23,368,000USD |
| Other Cashflows From Investing Activities | 2,306,000USD | 1,774,000USD | 1,151,000USD | 1,259,000USD | -114,730,000USD | -43,453,000USD | -27,583,000USD | -349,000USD |
| Other Cashflows From Financing Activities | -19,269,000USD | -14,711,000USD | -16,100,000USD | 233,885,000USD | 285,043,000USD | 209,725,000USD | 128,713,000USD | -15,953,000USD |
| Unclassified Operating Cash Flow | 11,406,000USD | 5,365,000USD | 4,490,000USD | 4,309,000USD | 5,688,000USD | — | 4,651,000USD | 4,813,000USD |
| Unclassified Investing Cash Flow | -24,948,000USD | 7,412,000USD | 43,120,000USD | 6,989,000USD | -1,632,000USD | — | — | 7,542,000USD |
| Investments | — | -149,450,000USD | -79,992,000USD | -81,269,000USD | 427,000USD | -111,000USD | -221,000USD | -23,909,000USD |
| Unclassified Financing Cash Flow | — | — | 163,646,000USD | -251,000,000USD | -316,914,000USD | -214,000,000USD | -145,502,000USD | — |
| Change To Liabilities | — | — | — | -7,755,000USD | 4,657,000USD | 16,919,000USD | -5,229,000USD | 4,908,000USD |
| Change To Inventory | — | — | — | — | -4,657,000USD | -12,427,000USD | 4,209,000USD | -742,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -4,351,000USD | 9,370,000USD | 180,000USD | 1,435,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Management Contract Revenues | 1,800,000 | USD | 0001140361-26-020025 |
| Q1 2026Quarterly · 2026-03-31 | Product | Net Patient Revenues | 164,328,000 | USD | 0001140361-26-020025 |
| Q1 2026Quarterly · 2026-03-31 | Product | Other Revenues Including Management Contract Revenues And Industrial Injury Prevention Services Revenues | 33,958,000 | USD | 0001140361-26-020025 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Industrial Injury Prevention Services Revenues | 30,610,000 | USD | 0001140361-26-020025 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Physical Therapy Operations | 167,676,000 | USD | 0001140361-26-020025 |
| Q4 2025Quarterly · 2025-12-31 | Segment | Industrial Injury Prevention Services Revenues | 28,947,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Physical Therapy Operations | 173,779,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Segment | Industrial Injury Prevention Services Revenues | 114,401,000 | USD | 0001140361-26-007170 |
| FY 2025Yearly · 2025-12-31 | Segment | Physical Therapy Operations | 666,589,000 | USD | 0001140361-26-007170 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Industrial Injury Prevention Services Revenues | 29,022,000 | USD | 0001140361-25-041152 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Physical Therapy Operations | 168,110,000 | USD | 0001140361-25-041152 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Industrial Injury Prevention Services Revenues | 29,052,000 | USD | 0001140361-25-029744 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Physical Therapy Operations | 168,292,000 | USD | 0001140361-25-029744 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Industrial Injury Prevention Services Revenues | 27,380,000 | USD | 0001140361-26-020025 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Physical Therapy Operations | 156,408,000 | USD | 0001140361-26-020025 |
| Q4 2024Quarterly · 2024-12-31 | Segment | Industrial Injury Prevention Services Revenues | 26,639,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Physical Therapy Operations | 153,808,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Segment | Industrial Injury Prevention Services Revenues | 96,912,000 | USD | 0001140361-26-007170 |
| FY 2024Yearly · 2024-12-31 | Segment | Physical Therapy Operations | 574,433,000 | USD | 0001140361-26-007170 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Industrial Injury Prevention Services Revenues | 25,319,000 | USD | 0001140361-25-041152 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Physical Therapy Operations | 142,714,000 | USD | 0001140361-25-041152 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Industrial Injury Prevention Services Revenues | 23,704,000 | USD | 0001140361-25-029744 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Physical Therapy Operations | 143,486,000 | USD | 0001140361-25-029744 |
| FY 2023Yearly · 2023-12-31 | Segment | Industrial Injury Prevention Services Revenues | 78,254,000 | USD | 0001140361-26-007170 |
| FY 2023Yearly · 2023-12-31 | Segment | Physical Therapy Operations | 526,548,000 | USD | 0001140361-26-007170 |
| Q3 2023Quarterly · 2023-09-30 | Product | Industrial Injury Prevention Services Revenues | 19,486,000 | USD | 0001140361-23-052081 |
| Q3 2023Quarterly · 2023-09-30 | Product | Management Contract Revenues | 2,389,000 | USD | 0001140361-23-052081 |
| Q3 2023Quarterly · 2023-09-30 | Product | Physical Therapy Operations — Net Patient Revenues | 127,243,000 | USD | 0001140361-23-052081 |
| Q3 2023Quarterly · 2023-09-30 | Product | Physical Therapy Operations — Other Revenues | 889,000 | USD | 0001140361-23-052081 |
| Q2 2023Quarterly · 2023-06-30 | Product | Industrial Injury Prevention Services Revenues | 19,246,000 | USD | 0001140361-23-038777 |
| Q2 2023Quarterly · 2023-06-30 | Product | Management Contract Revenues | 2,167,000 | USD | 0001140361-23-038777 |
| Q2 2023Quarterly · 2023-06-30 | Product | Physical Therapy Operations — Net Patient Revenues | 129,280,000 | USD | 0001140361-23-038777 |
| Q2 2023Quarterly · 2023-06-30 | Product | Physical Therapy Operations — Other Revenues | 792,000 | USD | 0001140361-23-038777 |
| Q1 2023Quarterly · 2023-03-31 | Product | Industrial Injury Prevention Services Revenues | 19,350,000 | USD | 0001140361-23-023184 |
| Q1 2023Quarterly · 2023-03-31 | Product | Management Contract Revenues | 1,779,000 | USD | 0001140361-23-023184 |
| Q1 2023Quarterly · 2023-03-31 | Product | Physical Therapy Operations — Net Patient Revenues | 126,581,000 | USD | 0001140361-23-023184 |
| Q1 2023Quarterly · 2023-03-31 | Product | Physical Therapy Operations — Other Revenues | 799,000 | USD | 0001140361-23-023184 |
| Q4 2022Quarterly · 2022-12-31 | Product | Industrial Injury Prevention Services Revenues | 18,392,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Product | Management Contract Revenues | 1,760,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Product | Physical Therapy Operations — Net Patient Revenues | 120,146,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Product | Physical Therapy Operations — Other Revenues | 884,000 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Segment | Industrial Injury Prevention Services Revenues | 77,052,000 | USD | 0001140361-25-006750 |
| FY 2022Yearly · 2022-12-31 | Segment | Physical Therapy Operations | 476,092,000 | USD | 0001140361-25-006750 |
| FY 2022Yearly · 2022-12-31 | Product | Industrial Injury Prevention Services Revenues | 77,052,000 | USD | 0001140361-23-009198 |
| FY 2022Yearly · 2022-12-31 | Product | Management Contract Revenues | 8,095,000 | USD | 0001140361-23-009198 |
| FY 2022Yearly · 2022-12-31 | Product | Physical Therapy Operations — Net Patient Revenues | 464,590,000 | USD | 0001140361-23-009198 |
| FY 2022Yearly · 2022-12-31 | Product | Physical Therapy Operations — Other Revenues | 3,407,000 | USD | 0001140361-23-009198 |
| Q3 2022Quarterly · 2022-09-30 | Product | Industrial Injury Prevention Services Revenues | 20,155,000 | USD | 0001140361-23-052081 |
| Q3 2022Quarterly · 2022-09-30 | Product | Management Contract Revenues | 1,984,000 | USD | 0001140361-23-052081 |
| Q3 2022Quarterly · 2022-09-30 | Product | Physical Therapy Operations — Net Patient Revenues | 116,710,000 | USD | 0001140361-23-052081 |
| Q3 2022Quarterly · 2022-09-30 | Product | Physical Therapy Operations — Other Revenues | 753,000 | USD | 0001140361-23-052081 |
| Q2 2022Quarterly · 2022-06-30 | Product | Industrial Injury Prevention Services Revenues | 19,437,000 | USD | 0001140361-23-038777 |
| Q2 2022Quarterly · 2022-06-30 | Product | Management Contract Revenues | 2,125,000 | USD | 0001140361-23-038777 |
| Q2 2022Quarterly · 2022-06-30 | Product | Physical Therapy Operations — Net Patient Revenues | 118,196,000 | USD | 0001140361-23-038777 |
| Q2 2022Quarterly · 2022-06-30 | Product | Physical Therapy Operations — Other Revenues | 898,000 | USD | 0001140361-23-038777 |
| Q1 2022Quarterly · 2022-03-31 | Product | Industrial Injury Prevention Services Revenues | 19,068,000 | USD | 0001140361-23-023184 |
| Q1 2022Quarterly · 2022-03-31 | Product | Management Contract Revenues | 2,226,000 | USD | 0001140361-23-023184 |
| Q1 2022Quarterly · 2022-03-31 | Product | Physical Therapy Operations — Net Patient Revenues | 109,538,000 | USD | 0001140361-23-023184 |
| Q1 2022Quarterly · 2022-03-31 | Product | Physical Therapy Operations — Other Revenues | 872,000 | USD | 0001140361-23-023184 |
| FY 2021Yearly · 2021-12-31 | Segment | Industrial Injury Prevention Services Revenues | 43,900,000 | USD | 0001140361-24-010454 |
| FY 2021Yearly · 2021-12-31 | Segment | Physical Therapy Operations | 451,122,000 | USD | 0001140361-24-010454 |
| FY 2021Yearly · 2021-12-31 | Product | Industrial Injury Prevention Services Revenues | 43,900,000 | USD | 0001140361-23-009198 |
| FY 2021Yearly · 2021-12-31 | Product | Management Contract Revenues | 9,853,000 | USD | 0001140361-23-009198 |
| FY 2021Yearly · 2021-12-31 | Product | Physical Therapy Operations — Net Patient Revenues | 438,330,000 | USD | 0001140361-23-009198 |
| FY 2021Yearly · 2021-12-31 | Product | Physical Therapy Operations — Other Revenues | 2,939,000 | USD | 0001140361-23-009198 |
| FY 2020Yearly · 2020-12-31 | Segment | Industrial Injury Prevention Services Revenues | 39,199,000 | USD | 0001140361-23-009198 |
| FY 2020Yearly · 2020-12-31 | Segment | Physical Therapy Operations | 383,770,000 | USD | 0001140361-23-009198 |
| FY 2020Yearly · 2020-12-31 | Product | Industrial Injury Prevention Services Revenues | 39,199,000 | USD | 0001140361-23-009198 |
| FY 2020Yearly · 2020-12-31 | Product | Management Contract Revenues | 8,410,000 | USD | 0001140361-23-009198 |
| FY 2020Yearly · 2020-12-31 | Product | Physical Therapy Operations — Net Patient Revenues | 373,340,000 | USD | 0001140361-23-009198 |
| FY 2020Yearly · 2020-12-31 | Product | Physical Therapy Operations — Other Revenues | 2,020,000 | USD | 0001140361-23-009198 |
| FY 2019Yearly · 2019-12-31 | Segment | Industrial Injury Prevention Services Revenues | 37,462,000 | USD | 0001140361-22-007247 |
| FY 2019Yearly · 2019-12-31 | Segment | Physical Therapy Operations | 444,507,000 | USD | 0001140361-22-007247 |
| FY 2019Yearly · 2019-12-31 | Product | Industrial Injury Prevention Services Revenues | 37,462,000 | USD | 0001140361-22-007247 |
| FY 2019Yearly · 2019-12-31 | Product | Management Contract Revenues | 8,676,000 | USD | 0001140361-22-007247 |
| FY 2019Yearly · 2019-12-31 | Product | Physical Therapy Operations — Net Patient Revenues | 433,345,000 | USD | 0001140361-22-007247 |
| FY 2019Yearly · 2019-12-31 | Product | Physical Therapy Operations — Other Revenues | 2,486,000 | USD | 0001140361-22-007247 |
| FY 2018Yearly · 2018-12-31 | Segment | Industrial Injury Prevention Services Revenues | 25,466,000 | USD | 0001140361-21-006642 |
| FY 2018Yearly · 2018-12-31 | Segment | Physical Therapy Operations | 428,445,000 | USD | 0001140361-21-006642 |
| FY 2018Yearly · 2018-12-31 | Product | Industrial Injury Prevention Services Revenues | 25,466,000 | USD | 0001140361-21-006642 |
| FY 2018Yearly · 2018-12-31 | Product | Physical Therapy Operations — Management Contract Revenues | 8,339,000 | USD | 0001140361-21-006642 |
| FY 2018Yearly · 2018-12-31 | Product | Physical Therapy Operations — Net Patient Revenues | 417,703,000 | USD | 0001140361-21-006642 |
| FY 2018Yearly · 2018-12-31 | Product | Physical Therapy Operations — Other Revenues | 2,403,000 | USD | 0001140361-21-006642 |
| FY 2017Yearly · 2017-12-31 | Product | Industrial Injury Prevention Services Revenues | 14,908,000 | USD | 0001140361-20-004374 |
| FY 2017Yearly · 2017-12-31 | Product | Management Contract Revenues | 6,275,000 | USD | 0001140361-20-004374 |
| FY 2017Yearly · 2017-12-31 | Product | Net Patient Revenues | 389,226,000 | USD | 0001140361-20-004374 |
| FY 2017Yearly · 2017-12-31 | Product | Other Revenues | 3,642,000 | USD | 0001140361-20-004374 |
| FY 2016Yearly · 2016-12-31 | Product | Industrial Injury Prevention Services Revenues | 0 | USD | 0001140361-19-005059 |
| FY 2016Yearly · 2016-12-31 | Product | Management Contract Revenues | 5,535,000 | USD | 0001140361-19-005059 |
| FY 2016Yearly · 2016-12-31 | Product | Net Patient Revenues | 348,839,000 | USD | 0001140361-19-005059 |
| FY 2016Yearly · 2016-12-31 | Product | Other Revenues | 2,172,000 | USD | 0001140361-19-005059 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.